Clinical trials recruiting in Hessen, Germany

Phase breakdown

Conditions recruiting in Hessen, Germany

Recruiting trials in Hessen, Germany

• A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT07680764 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
  NCT07265596 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hessen, Germany?

4 recruiting trials have at least one study site in Hessen, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.